Punctal and canalicular stenosis associated with systemic fluorouracil therapy
- 1 January 1995
- journal article
- case report
- Published by Springer Nature in Documenta Ophthalmologica
- Vol. 90 (1) , 1-6
- https://doi.org/10.1007/bf01203288
Abstract
Ocular side effects of systemic fluorouracil include excessive lacrimation, due to punctal and canalicular stenosis and fibrosis. Obstruction of the tear ducts after systemic therapy with fluorouracil is more frequent than is assumed. Five patients with breast cancer and punctal or canalicular stenosis are presented. Although complaints of epiphora usually resolve two weeks after cessation of systemic therapy, local antibiotics and steroids may be indicated. In patients with persisting complaints, and patients treated with fluorouracil for a prolonged period of time, prophylactic intubation of the tear ducts with silastic tubes has been advocated. (Conjunctivo)dacryocystorhinostomy may be unavoidable.Keywords
This publication has 24 references indexed in Scilit:
- Cyclophosphamide, Methotrexate, and 5-Fluorouracil (CMF)-Induced Ocular ToxicityCancer Investigation, 1990
- Ocular complications of systemic cancer chemotherapySurvey of Ophthalmology, 1989
- Fluorouracil Filtering Surgery Study One-Year Follow-upAmerican Journal of Ophthalmology, 1989
- Serious Corneal Complications of Glaucoma Filtering Surgery With Postoperative 5-FluorouracilAmerican Journal of Ophthalmology, 1987
- Ocular Toxicity of Antineoplastic AgentsOphthalmology, 1983
- Punctal-Canalicular Stenosis Related to Systemic Fluorouracil TherapyArchives of Ophthalmology (1950), 1981
- Lacrimation and 5-FluorouracilAnnals of Internal Medicine, 1978
- Cicatricial ectropion secondary to 5‐fluorouracil therapyMedical and Pediatric Oncology, 1977
- Neurotoxicity of Commonly Used Antineoplastic AgentsNew England Journal of Medicine, 1974
- Excessive Lacrimation From Fluorouracil TreatmentPublished by American Medical Association (AMA) ,1973